These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
358 related items for PubMed ID: 23926133
21. Knockout of Matrix Metalloproteinase 2 Opposes Hypertension- and Diabetes-induced Nephropathy. Hirata T, Fan F, Fan L, Amin G, White T, Geurts AM, Kojima N, Takahashi T, Miyata N, Williams J, Roman RJ. J Cardiovasc Pharmacol; 2023 Dec 01; 82(6):445-457. PubMed ID: 37643020 [Abstract] [Full Text] [Related]
22. Taurine ameliorates chronic streptozocin-induced diabetic nephropathy in rats. Trachtman H, Futterweit S, Maesaka J, Ma C, Valderrama E, Fuchs A, Tarectecan AA, Rao PS, Sturman JA, Boles TH. Am J Physiol; 1995 Sep 01; 269(3 Pt 2):F429-38. PubMed ID: 7573492 [Abstract] [Full Text] [Related]
23. Increased glomerular cell (podocyte) apoptosis in rats with streptozotocin-induced diabetes mellitus: role in the development of diabetic glomerular disease. Menini S, Iacobini C, Oddi G, Ricci C, Simonelli P, Fallucca S, Grattarola M, Pugliese F, Pesce C, Pugliese G. Diabetologia; 2007 Dec 01; 50(12):2591-9. PubMed ID: 17901943 [Abstract] [Full Text] [Related]
24. Altered renal hemodynamics is associated with glomerular lipid accumulation in obese Dahl salt-sensitive leptin receptor mutant rats. McPherson KC, Shields CA, Poudel B, Johnson AC, Taylor L, Stubbs C, Nichols A, Cornelius DC, Garrett MR, Williams JM. Am J Physiol Renal Physiol; 2020 Apr 01; 318(4):F911-F921. PubMed ID: 32068459 [Abstract] [Full Text] [Related]
25. Renoprotective effect of atorvastatin on STZ-diabetic rats through attenuating kidney-associated dysmetabolism. Zhou S, Zhao P, Li Y, Deng T, Tian L, Li H. Eur J Pharmacol; 2014 Oct 05; 740():9-14. PubMed ID: 25008071 [Abstract] [Full Text] [Related]
26. [Effect of xiaoke granule on blood glucose, urinary protein and glomerular morphology in rats with diabetic nephropathy]. Ji XM, Wang Q, Qi F. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Jun 05; 24(6):534-7. PubMed ID: 15250209 [Abstract] [Full Text] [Related]
27. Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism. Liang G, Song L, Chen Z, Qian Y, Xie J, Zhao L, Lin Q, Zhu G, Tan Y, Li X, Mohammadi M, Huang Z. Kidney Int; 2018 Jan 05; 93(1):95-109. PubMed ID: 28750927 [Abstract] [Full Text] [Related]
28. Renoprotective effects of combined SGLT2 and ACE inhibitor therapy in diabetic Dahl S rats. Kojima N, Williams JM, Slaughter TN, Kato S, Takahashi T, Miyata N, Roman RJ. Physiol Rep; 2015 Jul 05; 3(7):. PubMed ID: 26169541 [Abstract] [Full Text] [Related]
29. Lovastatin preserves renal function in experimental diabetes. Inman SR, Stowe NT, Cressman MD, Brouhard BH, Nally JV, Satoh S, Satodate R, Vidt DG. Am J Med Sci; 1999 Apr 05; 317(4):215-21. PubMed ID: 10210355 [Abstract] [Full Text] [Related]
33. Combination of leflunomide and benazepril reduces renal injury of diabetic nephropathy rats and inhibits high-glucose induced cell apoptosis through regulation of NF-κB, TGF-β and TRPC6. Li H, Wang Y, Zhou Z, Tian F, Yang H, Yan J. Ren Fail; 2019 Nov 05; 41(1):899-906. PubMed ID: 31552773 [Abstract] [Full Text] [Related]
34. Effects of garlic extract on TNF-α expression and oxidative stress status in the kidneys of rats with STZ + nicotinamide-induced diabetes. Ziamajidi N, Nasiri A, Abbasalipourkabir R, Sadeghi Moheb S. Pharm Biol; 2017 Dec 05; 55(1):526-531. PubMed ID: 27937047 [Abstract] [Full Text] [Related]
35. Renal injury in streptozotocin-diabetic Ren2-transgenic rats is mainly dependent on hypertension, not on diabetes. Hartner A, Cordasic N, Klanke B, Wittmann M, Veelken R, Hilgers KF. Am J Physiol Renal Physiol; 2007 Feb 05; 292(2):F820-7. PubMed ID: 17018847 [Abstract] [Full Text] [Related]
36. The effect of an aldose reductase inhibitor (Epalrestat) on diabetic nephropathy in rats. Itagaki I, Shimizu K, Kamanaka Y, Ebata K, Kikkawa R, Haneda M, Shigeta Y. Diabetes Res Clin Pract; 1994 Oct 05; 25(3):147-54. PubMed ID: 7851268 [Abstract] [Full Text] [Related]
37. Renoprotective effects of brown adipose tissue activation in diabetic mice. Cai YY, Zhang HB, Fan CX, Zeng YM, Zou SZ, Wu CY, Wang L, Fang S, Li P, Xue YM, Guan MP. J Diabetes; 2019 Dec 05; 11(12):958-970. PubMed ID: 31020790 [Abstract] [Full Text] [Related]
38. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes. Fang L, Radovits T, Szabó G, Mózes MM, Rosivall L, Kökény G. Nephrol Dial Transplant; 2013 Jul 05; 28(7):1751-61. PubMed ID: 23203993 [Abstract] [Full Text] [Related]
39. Renal mitochondrial impairment is attenuated by AT1 blockade in experimental Type I diabetes. de Cavanagh EM, Ferder L, Toblli JE, Piotrkowski B, Stella I, Fraga CG, Inserra F. Am J Physiol Heart Circ Physiol; 2008 Jan 05; 294(1):H456-65. PubMed ID: 18024545 [Abstract] [Full Text] [Related]
40. Rupatadine, a dual antagonist of histamine and platelet-activating factor (PAF), attenuates experimentally induced diabetic nephropathy in rats. Hafez HM, Abdel-Hakeem EA, Hassanein H. Naunyn Schmiedebergs Arch Pharmacol; 2020 Aug 05; 393(8):1487-1500. PubMed ID: 32200462 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]